#218 CPAP—Breath of life, or just hot air?
CLINICAL QUESTION
Does continuous positive airway pressure (CPAP) reduce cardiovascular disease (CVD) or mortality in patients with obstructive sleep apnea?
BOTTOM LINE
There is a lack of convincing evidence that CPAP reduces CVD or mortality in patients with moderate-to-severe obstructive sleep apnea. Adherence to CPAP treatment in most clinical trials is low (1.4-5.8 hours/night at one year). Modest clinically important improvements in daytime sleepiness have been demonstrated. Quality of life scales have also demonstrated improvement, although clinical significance is unclear.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
- Three meta-analyses of randomized controlled trials (RCTs).1,2,3 Patients were predominantly male, mean age >60 years, with moderate-to-severe obstructive sleep apnea.
- No statistical different in CPAP versus standard care or sham:
- CVD:1-3 7% CPAP versus 8% control (seven trials, 4,562 patients).1
- Cardiovascular death:1,2 9% CPAP versus 8% control (seven trials, 5,476 patients).1
- Acute coronary syndrome:1,2 3% CPAP versus 3% control (seven trials, 4,562 patients).1
- Stroke:1-3 4% CPAP versus 4% control (six trials, 4,171 patients).1
- Post-hoc analysis did not identify any significant relationship between CPAP and CVD regardless of apnea severity, length of follow-up, or adherence.1
- Limitations: Included studies somewhat heterogeneous with inclusion of central apnea patients in some outcomes, differences in length of follow-up (2-68 months), and adherence to CPAP (1.4-5.8 hours/night at one year).
- No statistical different in CPAP versus standard care or sham:
- Obstructive sleep apnea is associated with increased risk of CVD and mortality.4,5
- CPAP modestly improves daytime sleepiness by 1.6-3.8 on a 24-point scale, which is likely clinically detectable.6-10
- CPAP is associated with modest improvements in quality of life measures (example ~3.3-9.7 improvement on a 100-point scale)11 with uncertain clinical relevance.
- CPAP significantly decreases blood pressure (mean reduction 2.5 mmHg systolic and 2 mmHg diastolic).12
- Observational data suggests that CPAP use significantly reduces motor vehicle accidents.13 A large RCT (2,717 patients) reports a non-statistically significant trend towards injury reduction (7.4% versus 8.8%, p = 0.06).14
Latest Tools for Practice
#378 Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
What is the efficacy and safety of romosozumab in postmenopausal women with osteoporosis?
#377 How to slow the flow IV: Combined oral contraceptives
In premenopausal heavy menstrual bleeding due to benign etiology, do combined oral contraceptives (COC) improve patient outcomes?
#376 Testosterone supplementation for cis-gender men: Let’s (andro-)pause for a moment (Update)
What are the benefits and harms of testosterone supplementation in healthy cis-gender men or those with age-related low testosterone?
This is very interesting.
I am very surprised by lack of statistical correlation. A few of my patients have refused CPap and done well with good sleep hygiene ,weight reduction and stopping alcohol in evening.
Same theme as many of these articles.Canadian guide lines seem to be running there own coarse oblivious of statistical data